NXP900 is a new inhibitor of the SRC family of kinases with low nanomolar effect...
Arcus will commence research programmes against up to four targets for inflammat...
The Accelerating Medicines Partnership Bespoke Gene Therapy Consortium plans to ...
More than half of the top 20 global biopharmaceutical companies saw a fall in ma...
UniqQure sold a part of its royalty rights for haemophilia B gene therapy to dev...
The acquisition of Emergent’s portfolio includes vaccines for typhoid fever, cho...
The regulator requested more information that will need additional time and reso...
The investment will allow the company to continue to fund its growing organisati...
Physician staffing firm Envision Healthcare officially filed for bankruptcy, a m...
“A lot of generic companies use this pathway to get on the market. If we don’t h...
For the second time in one extended family, researchers have identified a person...
Biden announced he would nominate National Cancer Institute Director Monica Bert...
The FDA approved a new kind of drug to treat hot flashes, which could offer reli...
30 hopeful tech entrepreneurs crowded into an office in California this month, e...
A dispute between UnitedHealthcare and Phoenix Children’s Hospital is more about...
Changes to federal law are required so that when shortage drugs are urgently nee...
